P&G "Whistleblower" Raises Data Disclosure Issues
This article was originally published in The Pink Sheet Daily
Executive Summary
Actonel clinical trial investigator Blumsohn claims that Procter & Gamble improperly withheld data from a study of the osteoporosis drug.